Could common aspirin change cancer risk? tiny study investigates
NCT ID NCT03771651
Summary
This small, early-stage study is exploring whether taking low-dose aspirin for two weeks before surgery can reduce inflammation in the fallopian tubes. It involves 18 women who are already scheduled to have their fallopian tubes removed for non-cancer reasons. The main goal is to gather information to see if aspirin might influence biological changes linked to cancer, but it is not a treatment trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73117, United States
Conditions
Explore the condition pages connected to this study.